Screener
Eton Pharmaceuticals, Inc. ETON Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $26.85M+5.8% | $19.66M+12.9% | $25.94M+73.7% | $37.12M+83.2% | $25.38M+43.4% | ||
| $24.89M+72.2% | $13.41M-18.2% | $11.76M+119% | $13.08M+134% | $14.45M+197% | ||
| $10.14M-57.4% | $14.47M+6.2% | $15.42M+1.2% | $16.86M+770% | $23.79M+1,050% | ||
| $68.6M+0.2% | $53.25M+6.6% | $60.58M+47.7% | $72M+142% | $68.44M+169% | ||
| $352K+1,856% | $372K+1,591% | $326K+859% | $294K+791% | $18K-60.0% | ||
| $45.68M+38.9% | $43.74M+29.1% | $30.88M-11.5% | $31.88M+445% | $32.88M+437% | ||
| $115.81M+13.9% | $97.71M+16.3% | $92.11M+21.0% | $104.51M+192% | $101.68M+220% | ||
| $14.41M+18.6% | $13.49M+177% | $10.98M+163% | $14.26M+431% | $12.14M+469% | ||
| $8.83M+219% | $11.81M— | $8.79M— | $2.78M-32.7% | $2.77M-40.6% | ||
| $45.12M+16.9% | $44.18M+74.3% | $38.49M+93.0% | $44.18M+124% | $38.6M+112% | ||
| $19.08M-30.4% | $18.94M-36.9% | $21.77M-27.0% | $27.59M— | $27.41M— | ||
| $69.22M-10.9% | $67.1M+12.6% | $65.96M+27.6% | $81.38M+310% | $77.72M+323% | ||
| $28K+3.7% | $27K0.0% | $27K0.0% | $27K+3.8% | $27K+3.8% | ||
| -$99.36M+11.3% | -$110.94M-1.3% | -$112.49M-4.3% | -$113.98M-6.2% | -$112.05M-3.8% | ||
| $46.59M+94.4% | $30.62M+25.2% | $26.15M+7.1% | $23.13M+44.7% | $23.96M+78.0% | ||
| $115.81M+13.9% | $97.71M+16.3% | $92.11M+21.0% | $104.51M+192% | $101.68M+220% |
FAQ
- What are Eton Pharmaceuticals, Inc.'s total assets?
- Eton Pharmaceuticals, Inc. (ETON) holds $115.8M in total assets, up 13.9% year over year.
- How much debt does Eton Pharmaceuticals, Inc. have?
- Eton Pharmaceuticals, Inc. carries $28.8M in total debt against $46.6M of shareholders' equity, a debt-to-equity ratio of 0.62.
- How much cash does Eton Pharmaceuticals, Inc. have?
- Eton Pharmaceuticals, Inc. holds $26.8M in cash and equivalents.
- Can Eton Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 1.52 — current assets exceed current liabilities.
- Where does Eton Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from Eton Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
